NovoCure's total assets for Q2 2025 were $1.25B, a decrease of -0.23% from the previous quarter. NVCR total liabilities were $896.43M for the fiscal quarter, a 1.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.